6.64  -0.21 (-3.07%)		03-09 16:00
Open: 6.48 High: 6.89 Volume: 55,610		Pre. Close: 6.85 Low: 5.75 Market Cap: 53(M)

Short term
Mid term
Targets	6-month :	8.18	1-year :	9.58
Resists	First :	7.01	Second :	8.21
Pivot price	7.02
Supports	First :	5.07	Second :	4.21
MAs	MA(5) :	7.31	MA(20) :	6.62
	MA(100) :	5.65	MA(250) :	5.85
MACD	MACD :	0.3	Signal :	0.3
%K %D	K(14,3) :	57	D(3) :	72.9
RSI	RSI(14): 48.7
52-week	High :	14	Low :	4.15

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ ECOR ] has closed above bottom band by 35.3%. Bollinger Bands are 42.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	7.41 - 7.46	7.46 - 7.49
Low:	6.7 - 6.75	6.75 - 6.79
Close:	6.78 - 6.86	6.86 - 6.91

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Mon, 09 Mar 2026
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026 - The Manila Times

Mon, 09 Mar 2026
Bioelectronic firm electroCore to share 2025 results in Mar. 19 webinar - Stock Titan

Wed, 04 Mar 2026
electroCore, Inc. (ECOR) May Report Negative Earnings: Know the Trend Ahead of Q4 Release - Finviz

Sat, 28 Feb 2026
electroCore (NASDAQ:ECOR) Shares Down 2.1% - Here's Why - MarketBeat

Mon, 26 Jan 2026
electroCore's (ECOR) Price Target Lowered by HC Wainwright & Co. | ECOR Stock News - GuruFocus

Tue, 20 Jan 2026
electroCore Provides Preliminary Full-Year 2025 Business - GlobeNewswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	8 (M)
Shares Float	5 (M)
Held by Insiders	36.6 (%)
Held by Institutions	11.4 (%)
Shares Short	265 (K)
Shares Short P.Month	279 (K)

EPS	-1.72
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.15
Profit Margin	-47.5 %
Operating Margin	-33.2 %
Return on Assets (ttm)	-39.2 %
Return on Equity (ttm)	-337.9 %
Qtrly Rev. Growth	32.5 %
Gross Profit (p.s.)	3.2
Sales Per Share	3.73
EBITDA (p.s.)	-1.6
Qtrly Earnings Growth	0 %
Operating Cash Flow	-8 (M)
Levered Free Cash Flow	-2 (M)

PE Ratio	-3.89
PEG Ratio	0
Price to Book value	-47.43
Price to Sales	1.78
Price to Cash Flow	-6.73

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.